Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

February
28
2019

Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer

Medical Laser Pioneer and Veteran Entrepreneur Brings Over 30 Years of Experience to Company BOCA RATON, Fla., Feb. 28, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive…

February
27
2019

All about Keloid Scar Removal

Keloid scar removal is often an elusive task. This leaves many people living with unsightly scarring when the fact is they don’t need to! Here’s what you need to know about treating keloids most effectively….

February
26
2019

U.S. FDA Grants Market Clearance to Sensus Healthcare’s New Sculptura™ Radiation Oncology System

A Single Treatment during Surgery, Sculptura™ Eliminates Weeks of Post-Operative Radiation for Cancer Patients BOCA RATON, Fla., Feb. 26, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive…

February
14
2019

Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth

Shipped 27 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy